LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia

NCT04390217 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company focused on other clinical programs

Conditions

COVID-19
Coronavirus Disease 2019
Covid19
COVID-19 Pneumonia

Interventions

DRUG: LB1148
DRUG: Placebo

Sponsor

Leading BioSciences, Inc